Tiziana Enters a Collaboration Agreement with FHI Clinical to Conduct a Phase 2 Clinical Trial for Treating Hospitalized Severe COVID-19 Patients with Intranasal Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody

Omnidynamic Marketing

Matthew Durham

CMI Media Group’s

Building Better Brands

John Tenaglia

Moon Rabbit

Success Coach

Bud Bilanich

University of Denver

Vice President

Natalie McGroarty

Global Sales Lippincott® HCP Access Solutions, Wolters Kluwer

Scientific Storytelling

Frank Burrell

Deerfield Agency

Meeting Engagement

Pat Purcell

The Inception Company

Healthcare Challenger Brands

Frank X. Powers

Elevate Healthcare

Programmatic Marketing

Thomas Shea

Doceree

Chief Executive Officer

Blake Shewey

Snow Companies

Unified Customer Experience

Anil Bhaskar

Asentech LLC

Elevating Patient Partnerships

Jenny Sparano

SVP Propel Health

Increasing Engagement

Mike Viscel

Bionical Solutions Group

Brand Nourishment

Stacey Gandler

Calcium+Company

Medication Adherence

Laura Blair

ConnectiveRx

Increasing Engagement

Amy Giles

Bionical Solutions Group